Missing the target: Matrix metalloproteinase antitargets in inflammation and cancer

Trends in Pharmacological Sciences

Volumn 34, Issue 4, 2013, Pages 233-242

  Dufour, Antoine ^a   Overall, Christopher M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

angiogenesis; degradomics; proteomics; tumorigenesis

Indexed keywords

BATIMASTAT; COLLAGENASE 3; DOXYCYCLINE HYCLATE; GELATINASE A; GELATINASE B; ILOMASTAT; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MARIMASTAT; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 17; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 20; MATRIX METALLOPROTEINASE 21; MATRIX METALLOPROTEINASE 23; MATRIX METALLOPROTEINASE 24; MATRIX METALLOPROTEINASE 25; MATRIX METALLOPROTEINASE 26; MATRIX METALLOPROTEINASE 27; MATRIX METALLOPROTEINASE 28; MATRIX METALLOPROTEINASE INHIBITOR; NEUTROPHIL COLLAGENASE; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CHRONIC PERIODONTITIS; DRUG INDICATION; DRUG TARGETING; HUMAN; INFLAMMATION; LOW DRUG DOSE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

ANIMALS; HUMANS; INFLAMMATION; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES; MOLECULAR TARGETED THERAPY; NEOPLASMS;

EID: 84876019734     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2013.02.004     Document Type: Review

References (84)

1. D.B. Corry Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines FASEB J. 18 2004 995 997
2. C.M. Overall, and O. Kleifeld Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy Nat. Rev. Cancer 6 2006 227 239
3. L.M. Coussens Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 295 2002 2387 2392
4. S. Zucker Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment Oncogene 19 2000 6642 6650
5. W.C. Parks Matrix metalloproteinases as modulators of inflammation and innate immunity Nat. Rev. Immunol. 4 2004 617 629
6. G.A. McQuibban Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3 Science 289 2000 1202 1206
7. G.A. McQuibban Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo Blood 100 2002 1160 1167
8. J.H. Cox, and C.M. Overall Cytokine substrates: MMP regulation of inflammatory signaling molecules D. Edwards, The Cancer Degradome 2008 Springer 519 539
9. A.M.A. Houghton Macrophage elastase kills bacteria within murine macrophages Nature 460 2009 637 641
10. C.L.C. Wilson Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense Science 286 1999 113 117
11. J. Hu Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases Nat. Rev. Drug Discov. 6 2007 480 498
12. J. Caton, and M.E. Ryan Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD) Pharmacol. Res. 63 2011 114 120
13. M. Balbín Loss of collagenase-2 confers increased skin tumor susceptibility to male mice Nat. Genet. 35 2003 252 257
14. V. Montel Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression Cancer Res. 64 2004 1687 1694
15. J.T.J. Korpi Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer Br. J. Cancer 98 2008 766 775
16. S. Garcia Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model Arthritis Res. Ther. 12 2010 R224
17. J.H. Cox Matrix metalloproteinase 8 deficiency in mice exacerbates inflammatory arthritis through delayed neutrophil apoptosis and reduced caspase 11 expression Arthritis Rheum. 62 2010 3645 3655
18. P.A. Quintero Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1 alpha to reduce acute lung inflammation and injury in mice J. Immunol. 184 2010 1575 1588
19. M.M. Gueders Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation J. Immunol. 175 2005 2589 2597
20. A.M. Tester LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity PLoS ONE 2 2007 e312
21. D.B. Corry Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency Nat. Immunol. 3 2002 347 353
22. A.E. Starr Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16 J. Biol. Chem. 287 2012 5848 5860
23. A.E. Starr Biochemical characterization and N-terminomics analysis of leukolysin, the membrane-type 6 matrix metalloprotease (MMP25): chemokine and vimentin cleavages enhance cell migration and macrophage phagocytic activities J. Biol. Chem. 287 2012 13382 13395
24. O. Kleifeld Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products Nat. Biotechnol. 28 2010 281 288
25. G.S. Butler, and C.M. Overall Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting Nat. Rev. Drug Discov. 8 2009 935 948
26. B. Cauwe, and G. Opdenakker Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases Crit. Rev. Biochem. Mol. Biol. 45 2010 351 423
27. H.F.H. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing N. Engl. J. Med. 315 1986 1650 1659
28. L.J. McCawley A protective role for matrix metalloproteinase-3 in squamous cell carcinoma Cancer Res. 64 2004 6965 6972
29. A.Y. Savinov Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients Cancer Res. 66 2006 2716 2724
30. A. Krüger Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis Cancer Res. 61 2001 1272 1275
31. C. Kopitz Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling Cancer Res. 67 2007 8615 8623
32. M.S. O'Reilly Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance J. Biol. Chem. 274 1999 29568 29571
33. H.B. Acuff Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer Cancer Res. 66 2006 7968 7975
34. Z. Dong Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma Cell 88 1997 801 810
35. A.M.A. Houghton Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases Cancer Res. 66 2006 6149 6155
36. M.M. Jost Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19-deficient mice Cancer Res. 66 2006 5234 5241
37. C.M. Overall, and C.P. Blobel In search of partners: linking extracellular proteases to substrates Nat. Rev. Mol. Cell Biol. 8 2007 245 257
38. C.J. Morrison Matrix metalloproteinase proteomics: substrates, targets, and therapy Curr. Opin. Cell Biol. 21 2009 645 653
39. M.D. Martin Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background Cancer Res. 68 2008 6251 6259
40. K.L.K. Andarawewa Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression Cancer Res. 63 2003 5844 5849
41. J.P.J. Witty Decreased tumor formation in 7,12-dimethylbenzanthracene- treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis Cancer Res. 55 1995 1401 1406
42. J.L. Johnson A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice Arterioscler. Thromb. Vasc. Biol. 31 2011 528 535
43. G.S. Butler Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding Mol. Cell. Biol. 28 2008 4896 4914
44. U. auf dem Keller Terminomics reveals increased vascular permeability and complement activation by MMP2 cleavage of complement 1 inhibitor in skin inflammation Sci. Signal 6 2013 rs26 http://dx.doi.org/10.1126/scisignal.2003512
45. R.A. Dean Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis Mol. Cell. Biol. 27 2007 8454 8465
46. P.F. Lange, and C.M. Overall TopFIND, a knowledgebase linking protein termini with function Nat. Methods 8 2011 703 704
47. A. Szklarczyk Cleavage of neuronal synaptosomal-associated protein of 25 kDa by exogenous matrix metalloproteinase-7 J. Neurochem. 102 2007 1256 1263
48. R.A. Dean Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx Blood 112 2008 3455 3464
49. T. Takino Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases Oncogene 22 2003 4617 4626
50. A.A. Belaaouaj Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation J. Biol. Chem. 275 2000 27123 27128
51. N. Sela-Passwell Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential Nat. Med. 18 2012 143 147
52. L. Devel Development of selective inhibitors and substrate of matrix metalloproteinase-12 J. Biol. Chem. 281 2006 11152 11160
53. L. Devel Insights from selective non-phosphinic inhibitors of MMP-12 tailored to fit with an S1′ loop canonical conformation J. Biol. Chem. 285 2010 35900 35909
54. L. Devy Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis Cancer Res. 69 2009 1517 1526
55. R. Shimizu-Hirota MT1-MMP regulates the PI3K{delta}{middle dot}Mi-2/NuRD-dependent control of macrophage immune function Genes Dev. 26 2012 395 413
56. C. López-Otín, and C.M. Overall Protease degradomics: a new challenge for proteomics Nat. Rev. Mol. Cell Biol. 3 2002 509 519
57. C.M. Overall Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites Mol. Biotechnol. 22 2002 51 86
58. M.M. Pollak The insulin and insulin-like growth factor receptor family in neoplasia: an update Nat. Rev. Cancer 12 2012 159 169
59. T. Itoh The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis J. Immunol. 169 2002 2643 2647
60. P. Garg Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis J. Immunol. 177 2006 4103 4112
61. J-Y.C. Hsu Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury J. Neurosci. 26 2006 9841 9850
62. M. Wang Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response Proc. Natl. Acad. Sci. U.S.A. 96 1999 6885 6889
63. C.K.F. Li Impaired immunity to intestinal bacterial infection in stromelysin-1 (matrix metalloproteinase-3)-deficient mice J. Immunol. 173 2004 5171 5179
64. S.E. Dunsmore Matrilysin expression and function in airway epithelium J. Clin. Invest. 102 1998 1321 1331
65. L.H. Palavalli Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma Nat. Genet. 41 2009 518 520
66. L.M.L. Coussens MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis Cell 103 2000 481 490
67. Y. Hamano Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin Cancer Cell 3 2003 589 601
68. B.B. Cauwe Deficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune disease J. Autoimmun. 36 2011 239 252
69. K. Shchors Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis Oncogene 2012 10.1038/onc.2012.60
70. L.E.L. Littlepage Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression Cancer Res. 70 2010 2224 2234
71. S.J. McMillan Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation J. Immunol. 172 2004 2586 2594
72. R. Renckens Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis J. Immunol. 176 2006 3735 3741
73. A-M. Calander Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis Microbes Infect. 8 2006 1434 1439
74. J. Tang Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice J. Cereb. Blood Flow Metab. 24 2004 1133 1145
75. F.F. Margheri Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12 Arthritis Rheum. 62 2010 2488 2498
76. S. Lavilla-Alonso Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases development Gene Ther. 19 2011 126 134
77. A. Weaver An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization FASEB J. 19 2005 1668 1670
78. D. Stickens Altered endochondral bone development in matrix metalloproteinase 13-deficient mice Development 131 2004 5883 5895
79. K. Holmbeck The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone J. Cell Sci. 118 2005 147 156
80. J.J. Caterina Enamelysin (matrix metalloproteinase 20)-deficient mice display an amelogenesis imperfecta phenotype J. Biol. Chem. 277 2002 49598 49604
81. E. Beniash Formation of the dentino-enamel interface in enamelysin (MMP-20)-deficient mouse incisors Eur. J. Oral Sci. 114 Suppl. 1 2006 24 29 discussion 39-41, 379
82. S. Rangaraju Potassium channel modulation by a toxin domain in matrix metalloprotease 23 J. Biol. Chem. 285 2010 9124 9136
83. K. Komori Absence of mechanical allodynia and Abeta-fiber sprouting after sciatic nerve injury in mice lacking membrane-type 5 matrix metalloproteinase FEBS Lett. 557 2004 125 128
84. A.M. Manicone Epilysin (matrix metalloproteinase-28) contributes to airway epithelial cell survival Respir. Res. 12 2011 144